trending Market Intelligence /marketintelligence/en/news-insights/trending/MK-_2wRfx3G_WCKw4VoSSA2 content esgSubNav
In This List

Kura Oncology prices $50.1M common stock offering

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


Kura Oncology prices $50.1M common stock offering

Kura Oncology Inc. priced an underwritten public offering of 7,700,000 common shares at $6.50 apiece, for expected gross proceeds of about $50.1 million.

The company also granted underwriters a 30-day option to buy up to an additional 1,155,000 common shares.

The offering is expected to close on or around Aug. 16, subject to customary closing conditions.

Leerink Partners and Cowen are acting as joint book-running managers for the offering, with JMP Securities and Oppenheimer & Co. as co-lead managers.